17
Participants
Start Date
May 31, 2010
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
somatotropin
Subjects will receive 5 mg somatotropin (growth hormone) pens with cartridges. Subcutaneous injections are to be given every evening around bedtime. Dosing regimen: 50 mcg/kg/day to be adjusted at 4 month intervals to the closest 0.1 mg. Subjects will be given 12 months of treatment (from 12 to 24 months of life). Subjects will visit their pediatrician or pediatric endocrinologist at 4 and 8 months of life.
University of North Carolina at Chapel Hill, Chapel Hill
Collaborators (1)
Pfizer
INDUSTRY
Rebecca Knickmeyer Santelli, PhD
OTHER